Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 6/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | HTR2B | P41595 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6283809 | 0.76 | GABRA1 (0.50) | GABRA1GABRB1LMNACA1CA2 | |
| SCHEMBL15698348 | 0.75 | LMNA (0.52) | GABRA1GABRB1LMNACA1CA2 | |
| SCHEMBL4613445 | 0.75 | GABRA1 (0.54) | GABRA1GABRB1LMNACA1CA2 | |
| SCHEMBL29810169 | 0.74 | GABRA1 (0.48) | GABRA1GABRB1LMNACA1CA2 | |
| Biclotymol SCHEMBL31496050 | 0.74 | HIF1A (0.54) | GABRA1GABRB1LMNACA1CA2 | |
| SCHEMBL17160048 | 0.74 | GABRA1 (0.48) | GABRA1GABRB1LMNACA1CA2 | |
| SCHEMBL572969 | 0.74 | GABRA1 (0.48) | GABRA1GABRB1LMNACA1CA2 | |
| Biclotymol SCHEMBL70634 | 0.74 | HIF1A (0.54) | GABRA1GABRB1LMNACA1CA2 | |
| SCHEMBL2787398 | 0.71 | FABP3 (0.46) | GABRA1GABRB1LMNACA1CA2 | |
| SCHEMBL5642327 | 0.71 | GABRA1 (0.46) | GABRA1GABRB1LMNACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150336885-A1 | PROCESS FOR PREPARING 2,2'-SELENOBIARYL ETHERS OR 4,4'-SELENOBIARYL ETHERS USING SELENIUM DIOXIDE | EVONIK DEGUSSA GMBH (DE) | 2015-11-26 | — | — | US | claimed |
| EP-2949646-A1 | METHOD FOR THE PREPARATION OF 2,2'SELENOBIARYLETHERS OR 4,4'SELENOBIARYLETHERS USING SELENIUM DIOXIDE | Evonik Degussa GmbH (DE) | 2015-12-02 | — | — | EP | disclosed |
| US-20150336885-A1 | PROCESS FOR PREPARING 2,2'-SELENOBIARYL ETHERS OR 4,4'-SELENOBIARYL ETHERS USING SELENIUM DIOXIDE | EVONIK DEGUSSA GMBH (DE) | 2015-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150336885-A1 | PROCESS FOR PREPARING 2,2'-SELENOBIARYL ETHERS OR 4,4'-SELENOBIARYL ETHERS USING SELENIUM DIOXIDE | SELENOI, SCLY, SPIN4 | GABRA1 3326/4885GABRB1 2546/4885LMNA 4118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.